Editorial, medical review, AI use and corrections policy
This policy explains how Medil AI prepares public product guidance and medication-information content, when qualified medical review is required, how AI assistance is disclosed, and how errors are corrected.
Contents
Scope and editorial responsibility
Medil publishes product guidance, safety limitations, source-methodology pages and explanations of information shown by the app. The Medil Health Technologies Ltd editorial team is responsible for publication. A page must identify its author or responsible editorial entity, its publication or update date, and its review status.
Product guidance describes how Medil works. It must not tell a person which medication to use, change a dose, diagnose a condition, or imply regulator or clinician endorsement.
Source selection and citations
Medication facts should use the most direct appropriate primary source: a regulator, national registry, official product notice, or manufacturer material published through an official channel. The exact document or record should be linked where practical. A regulator homepage alone is not evidence for a specific claim.
Secondary literature may explain context but must not silently replace current official product information. Market-specific claims should use the relevant authority, such as FDA or DailyMed in the United States, HSA in Singapore, PMDA in Japan, or MFDS in South Korea.
When medical review is required
Content that interprets treatment, safety, interactions, contraindications, clinical evidence or patient-specific implications requires review by a named, appropriately qualified healthcare professional before publication. The page must display that reviewer’s name, qualifications, jurisdiction, relevant expertise and medical-review date.
No reviewer may be implied. Product-interface instructions and descriptions of Medil features may receive editorial or product review without being labelled “medically reviewed.” If qualified review has not occurred, the page must say so where readers could otherwise mistake it for clinical guidance.
AI-assisted content
AI tools may assist with drafting, translation, summarization, classification or consistency checks. A human remains responsible for publication. AI output must be checked against cited sources, product behavior and policy constraints; it must not be presented as an official source or as the opinion of a healthcare professional.
Material AI assistance is disclosed when it helps a reader assess reliability. Translations and summaries must preserve access to the original official information and clearly state that errors or omissions are possible.
Reusable provenance labels
What page dates mean
Published
The first public release of the page.
Updated
A material change to content, sources, product behavior or limitations. Cosmetic build changes alone do not justify a new content date.
Last medically reviewed
The date a named qualified reviewer assessed the medical interpretation. This label is omitted when no medical review was required or performed.
Corrections policy
Readers can report an error, outdated source, mistranslation, accessibility problem or undisclosed conflict by emailing support@medil.ai. Include the page URL, the disputed statement and supporting evidence when available.
Reports are triaged by potential harm and reach. A credible safety-related error is restricted or corrected as soon as it can be verified. Material corrections update the visible date and, when context would otherwise be lost, include a correction note explaining what changed. Minor spelling or formatting changes do not require a correction notice.
Questions and corrections
Contact support@medil.ai. Privacy and deletion requests are governed by the separate privacy policy.